XML 26 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock Outstanding
Common Stock
Value of Shares Held in Rabbi Trust at Cost
Deferred Compensation and Other Retirement Benefit Obligations
Additional Paid in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income/(Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Common Stock, Shares, Outstanding     34,377,388              
Financing Receivable, Allowance for Credit Losses, Effect of Change in Method $ (1,137,000)                  
Net income 51,653,000             $ 51,653,000    
Other comprehensive income 33,676,000                 $ 33,676,000
Cash dividends declared per common share (in dollars per share)               $ 0.92    
Common dividend declared (30,554,000)             $ (30,554,000)    
Proceeds from exercise of stock options, net of cash paid     873              
Stock based compensation 2,429,000           $ 2,429,000      
Restricted stock awards issued, net of awards surrendered     49,292              
Restricted stock awards issued, net of awards surrendered (1,183,000)     $ 1,000     (1,184,000)      
Shares issued under direct stock purchase plan     14,557              
Shares issued under direct stock purchase plan 1,092,000     0     1,092,000      
Stock Repurchased During Period, Shares     (1,500,000)              
Stock Repurchased During Period, Value (95,091,000)     (15,000)     (95,076,000)      
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits         $ 86,000 $ (86,000)        
Increase (Decrease) in Deferred Compensation 0                  
Period End Balance at Jun. 30, 2020 1,671,692,000     328,000 (4,649,000) 4,649,000 942,685,000 676,834,000   51,845,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Financing Receivable, Allowance for Credit Losses, Effect of Change in Method, net of tax. 817,000                  
Off-Balance Sheet, Credit Loss, Liability, Change in Method, Credit Loss Expense (Reversal) (1,000,000.0)                  
Off-Balance Sheet, Credit Loss, Liability, Change in Method, Credit Loss Expense (Reversal), net of tax. 736,000                  
Proceeds from exercise of stock options, net of cash paid (26,000)     0     (26,000)      
Common Stock, Shares, Outstanding     33,260,005              
Net income 24,902,000             $ 24,902,000    
Other comprehensive income 2,117,000                 2,117,000
Cash dividends declared per common share (in dollars per share)               $ 0.46    
Common dividend declared (15,152,000)             $ (15,152,000)    
Proceeds from exercise of stock options, net of cash paid     873              
Stock Repurchased During Period, Value, as a result of Stock Options Exercised (26,000)           (26,000)      
Stock based compensation 1,579,000           1,579,000      
Restricted stock awards issued, net of awards surrendered     6,761              
Restricted stock awards issued, net of awards surrendered (51,000)           (51,000)      
Shares issued under direct stock purchase plan     7,548              
Shares issued under direct stock purchase plan 532,000           532,000      
Stock Repurchased During Period, Shares     (333,077)              
Stock Repurchased During Period, Value (21,865,000)     (3,000)     (21,862,000)      
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits         (45,000) 45,000        
Increase (Decrease) in Deferred Compensation 0                  
Period End Balance at Jun. 30, 2020 $ 1,671,692,000     328,000 (4,649,000) 4,649,000 942,685,000 676,834,000   51,845,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Common Stock, Shares, Outstanding     32,942,110              
Common Stock, Shares, Outstanding 32,965,692   32,965,692              
Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) [1]   $ 1,553,000             $ 1,553,000  
Net income $ 79,283,000             $ 79,283,000    
Other comprehensive income (11,128,000)                 (11,128,000)
Cash dividends declared per common share (in dollars per share)               $ 0.96    
Common dividend declared (31,711,000)             $ (31,711,000)    
Proceeds from exercise of stock options, net of cash paid     4,744              
Stock Repurchased During Period, Value, as a result of Stock Options Exercised (57,000)           (57,000)      
Stock based compensation 2,760,000           2,760,000      
Restricted stock awards issued, net of awards surrendered     54,558              
Restricted stock awards issued, net of awards surrendered (1,243,000)     1,000     (1,244,000)      
Shares issued under direct stock purchase plan     12,865              
Shares issued under direct stock purchase plan 1,033,000           1,033,000      
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits         (50,000) 50,000        
Increase (Decrease) in Deferred Compensation 0                  
Period End Balance at Jun. 30, 2021 1,741,622,000     329,000 (3,116,000) 3,116,000 948,130,000 763,596,000   29,567,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Common Stock, Shares, Outstanding     33,024,882              
Net income 37,572,000             $ 37,572,000    
Other comprehensive income 2,410,000                 2,410,000
Cash dividends declared per common share (in dollars per share)               $ 0.48    
Common dividend declared (15,859,000)             $ (15,859,000)    
Stock based compensation 1,610,000           1,610,000      
Restricted stock awards issued, net of awards surrendered     6,452              
Restricted stock awards issued, net of awards surrendered (23,000)           (23,000)      
Shares issued under direct stock purchase plan     6,525              
Shares issued under direct stock purchase plan 541,000           541,000      
Increase (Decrease) in Deferred Compensation and Other Retirement Benefits         (36,000) 36,000        
Increase (Decrease) in Deferred Compensation 0                  
Period End Balance at Jun. 30, 2021 $ 1,741,622,000     $ 329,000 $ (3,116,000) $ 3,116,000 $ 948,130,000 $ 763,596,000   $ 29,567,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Common Stock, Shares, Outstanding 33,037,859   33,037,859              
[1] Represents adjustment needed to reflect the cumulative impact on retained earnings pursuant to the Company's adoption of Accounting Standards Update 2016-13. The adjustment presented includes $1.1 million ($817,000, net of tax) attributable to the change in accounting methodology for estimating the allowance for credit losses and $1.0 million ($736,000, net of tax) related to the reserve for unfunded commitments resulting from the Company's adoption of the standard. Amount shown in the table above is presented net of tax.